RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act
The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…
CertaraFebruary 10, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
CertaraFebruary 9, 2023
Podcast interview with Dr. Elvira Müller. EU joint HTA – decided, but how will it be executed and how should companies prepare
In Europe, there are at least as many reimbursement assessment processes in place as European…
CertaraFebruary 7, 2023
FDA awards new grants to support developing & assessing complex generic drugs
Certara’s Simcyp physiologically-based pharmacokinetic (PBPK) Simulator is being used to verify and expand biosimulation models…
CertaraFebruary 7, 2023
Artificial Intelligence: What is it & how can it accelerate rare disease drug development?
Large & complex information streams present opportunities for the AI data scientist to aid in…
CertaraFebruary 3, 2023
